Memorial Sloan Kettering Cancer Center
2021 ASCO Updates on KEYLYNK-013 Study for Newly Diagnosed LS-SCLC: Pembro+CCRT Followed by Pembro +/- Olaparib vs. CCRT
By
Memorial Sloan Kettering Cancer Center
FEATURING
Andreas Rimner
By
Memorial Sloan Kettering Cancer Center
FEATURING
Andreas Rimner
Login to view comments.
Click here to Login